Remote delivery of thrombolytics prior to transfer to a regional burn center for tissue salvage in frostbite: A single center experience of 199 patients.

Abstract

While much has been published on efficacy and safety of systemic thrombolytics in the treatment of acute frostbite, there has been limited investigation into administration outside a tertiary care setting. Here, we present a single-center experience with remote initiation of intravenous tissue plasminogen activator (tPA) at referring hospitals prior to transfer to a regional burn center. A modified Hennepin Quantification Score based on tissue involvement was used to determine eligibility for tPA and to quantify severity of amputation. This is a retrospective review of patients with acute frostbite of the digits admitted to a single verified burn center over a five-year period. Of 199 patient admissions, 40 received tPA remotely pre-transfer, 32 received tPA on admission to our institution, and 127 patients did not qualify for tPA therapy according to the protocol. Comparing patients who required any amputation (n=99, 49.7%) to those who did not, patients who received remote tPA had lower odds of any amputation compared to both those receiving tPA at our institution (OR 0.19, 95% CI 0.05 - 0.65, p=0.01) and the group receiving no tPA (OR 0.14, 95% CI 0.05 - 0.40, p<0.001) after controlling for confounders. Only one patient receiving pre-transfer tPA according to protocol (2.3%) had a significant bleeding event requiring transfusion. These results support the protocolized use of thrombolytic therapy for frostbite prior to transfer to a tertiary center.